Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Oral methotrexate therapy: pro and con].

H Zachariae

    Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Methotrexate is an effective treatment for severe psoriasis, but requires careful monitoring due to potential liver toxicity. Regular lab tests and liver biopsies are essential for managing risks associated with this long-term psoriasis therapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Have methotrexate-induced liver fibrosis and cirrhosis become rare? A matter for reappraisal of routine liver biopsies.

    Dermatology (Basel, Switzerland)·2005
    Same author

    Self-reported stress reactivity and psoriasis-related stress of Nordic psoriasis sufferers.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2003
    Same author

    Quality of life in 6497 Nordic patients with psoriasis.

    The British journal of dermatology·2002
    Same author

    Treatment of psoriasis in the Nordic countries: a questionnaire survey from 5739 members of the psoriasis associations data from the Nordic Quality of Life Study.

    Acta dermato-venereologica·2001
    Same author

    Oesophageal pressure-cross-sectional area distributions and secondary peristalsis in relation to subclassification of systemic sclerosis.

    Neurogastroenterology and motility·2001
    Same author

    The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: a 10-year follow-up.

    The British journal of dermatology·2001
    Same journal

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
    Same journal

    [Viral infections of the skin].

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
    Same journal

    [Viral exanthems in children].

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
    Same journal

    [Erratum to: Digital health applications and data protection].

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
    Same journal

    [Virus-induced exanthems in returning travellers].

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
    Same journal

    [Venous ulcus cruris-Surgical treatment].

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
    See all related articles

    Area of Science:

    • Dermatology
    • Hepatology
    • Pharmacology

    Background:

    • Severe psoriasis presents a significant therapeutic challenge.
    • Methotrexate has been a long-standing treatment option for psoriasis for over three decades.
    • Understanding the risk-benefit profile of methotrexate is crucial for patient management.

    Purpose of the Study:

    • To review the established use and risk-benefit ratio of methotrexate in treating severe psoriasis.
    • To highlight essential monitoring parameters and potential risks associated with methotrexate therapy.
    • To emphasize the importance of regular laboratory and liver biopsy assessments during methotrexate treatment.

    Main Methods:

    • Review of extensive clinical experience with methotrexate for psoriasis over 30 years.

    Related Experiment Videos

  • Analysis of the risk-benefit ratio, including contraindications and side effects.
  • Emphasis on monitoring requirements: kidney, liver, bone marrow function, and liver biopsy.

    • Main Results:

    • Methotrexate is a viable therapeutic option for severe psoriasis.
    • Normal kidney, liver, and bone marrow function are prerequisites for treatment.
    • Hepatotoxicity, including fibrosis and cirrhosis (especially above 1.5g cumulative dose), is a known risk, though not rapidly progressive.
    • Pregnancy is an absolute contraindication.

    Conclusions:

    • Methotrexate offers a treatment choice for severe psoriasis, but necessitates stringent monitoring.
    • Regular laboratory controls and liver biopsies are critical for safe and effective long-term use.
    • The established experience with methotrexate provides a foundation for its continued, albeit cautious, application in psoriasis management.